Printer Friendly
The Free Library
14,537,061 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Takara Bio Discovers Seven New RNA Interference Enzymes.


Tokyo, Japan, Aug 18, 2005 - (JCNN JCNN Japan Corporate News Network ) - Takara Bio announced on August 17 that it has discovered seven new RNA interference enzymes by screening various bacteria. The newly-discovered enzymes can identify and cleave cleat, cleave

claw of any cloven-footed animal.
 specific sequences of single-strand RNAs.

In addition, the company has confirmed the effect of MazF, a kind of RNA interference enzyme, on an HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  infection. Specifically, MazF can induce the death of cells into which the Tat genes are introduced.

Takara Bio envisages the three following applications for RNA interference enzymes: HIV gene therapy, the Single Protein Production system that enables targeted proteins to be produced, and reagents for RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
 engineering.

Details of theses findings will be presented at the 28th Annual Meeting of the Molecular Biology Society of Japan to be held from December 7 to 10.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Aug 19, 2005
Words:146
Previous Article:Japan Lifeline Reports AMPLATZER Septal Occulader Used for Atrial Septal Defect Treatment in Japan.
Next Article:Matsushita Ecology Systems Develops Supersonic Sludge Reduction System for Small Effluent Treatment Facilities.



Related Articles
NANOSPHERE/TAKARO BIO FORM DEVELOP/DISTRIBUTE ALLIANCE.
Takara Bio Establishes Innovative Method to Commercially Produce Chalcones.
Takara Bio Releases High-fidelity PCR Enzyme PrimeSTAR HS DNA Polymerase.
Takara Bio Introduces New Protein Expression System.
Enzyme measures RNA using natural ruler.(BIOLOGY)(Brief Article)
Takara Bio Chinese Subsidiary to Expand Lines of Business, Files Chinese Clinical Trial Application.
Takara Bio to Release Two New Enzymes.
Takara Bio, Chinese CDC to Collaborate in AIDS Research.
Rapid genome sequencing of RNA viruses.(DISPATCHES)
Takara Bio Grants Transgenomic License for LA-PCR Technology.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles